| COVID-19 vaccine candidates and vaccine development platforms available worldwide N Duman, Z ALzaidi, B Aynekin, D Taskin, B Demirors, A Yildirim, ... Journal of pharmaceutical analysis 11 (6), 675-682, 2021 | 14 | 2021 |
| Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy N Karasu, H Akalin, N Gokce, A Yildirim, M Demir, H Kulak, S Celik, ... Medical Oncology 38 (10), 120, 2021 | 3 | 2021 |
| Diagnosing Alström syndrome in a patient followed up with syndromic obesity for years M Yakubi, D Cicek, M Demir, A Yildirim, N Hatipoglu, Y Ozkul, M Dundar Intractable & Rare Diseases Research 11 (2), 84-86, 2022 | 2 | 2022 |
| Oncogenic genomic changes in cancer A Yildirim, H Akalin, M Dundar Oncology: Genomics, Precision Medicine and Therapeutic Targets, 25-38, 2023 | 1 | 2023 |
| Artificial cells: A potentially groundbreaking field of research and therapy MS Dundar, AB Yildirim, DT Yildirim, H Akalin, M Dundar The EuroBiotech Journal 8 (1), 55-64, 2024 | | 2024 |
| A New Case of Translocation T (2; 7)(p23; q35) in Recurrent Pregnancy Loss A Yildirim, D Taskin, R Atasay, M Dundar Clinical medicine & research 21 (1), 53-55, 2023 | | 2023 |
| Molecular analysis of SMN1 and SMN2 genes with the patients pre-diagnosed with spinal muscular atrophy. N Karasu, ME Dogan, A Yildirim, D Taskin, Y Ozkul, C Saatci, H Per, ... Erciyes Medical Journal 41 (S1), 47-48, 2019 | | 2019 |
| European Biotechnology Congress 2022 M Dundar, I Marova The EuroBiotech Journal 7 (1), 1-3, 0 | | |
| A case with extra derivative choromosome 22 R Atasay, M Demir, M Erdoğan, A Yıldırım, C Gündüz, S Kumandaş, ... | | |
| European biotechnology congress 2021 N Georgieva, D Danalev, M Dundar | | |
